Development and Evaluation of a Vibroacoustic Therapy for Cardiovascular Health in Post-Menopausal Women

This study presents the design and implementation of a vibroacoustic therapy (VAT) intervention aimed at improving cardiovascular health in post-menopausal women. The intervention was motivated by the elevated risk of cardiovascular diseases (CVD) in post-menopausal women due to physiological changes such as reduced estrogen levels, which contribute to increased arterial stiffness and elevated blood pressure. While traditional management approaches focus on lifestyle modifications and pharmacological interventions, there is growing interest in complementary therapies like VAT, which utilizes low-frequency sound waves to induce physiological responses potentially beneficial to cardiovascular health. The participants were randomly assigned to two groups: an intervention group receiving VAT and a control group on a waitlist. Cardiovascular parameters, including heart rate (HR), systolic blood pressure (sBP), diastolic blood pressure (dBP), stroke volume (SV), and cardiac output (CO), were assessed through an active stand test. Additionally, the Menopause Rating Scale (MRS) and Menopause-Specific Quality of Life (MENQOL) questionnaires were administered to evaluate menopausal symptoms and quality of life, respectively. The results of this pilot study indicated that VAT had a positive effect on cardiovascular function, particularly in maintaining heart rate and blood pressure during posture changes. Improvements were also reported in menopausal symptoms and quality of life. However, due to the small sample size, these findings should be interpreted with caution. Larger-scale studies are needed to validate these preliminary results and fully explore VAT's potential as a complementary therapy for cardiovascular health in post-menopausal women.